Jury sides with Philadelphia biotech firm in multimillion-dollar commission payment dispute

A federal jury in Atlanta ruled in favor of Hemispherx Biopharma Inc., which was sued by a brokerage firm that claimed it was owed more than $6 million in commissions from the Philadelphia biotechnology company...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.